Published in PLoS One on September 25, 2014
The Specific Roles of JAK/STAT Signaling Pathway in Sepsis. Inflammation (2015) 0.81
High mobility group box 1 induces the activation of the Janus kinase 2 and signal transducer and activator of transcription 3 (JAK2/STAT3) signaling pathway in pancreatic acinar cells in rats, while AG490 and rapamycin inhibit their activation. Bosn J Basic Med Sci (2016) 0.76
Gram Negative Bacterial Inflammation Ameliorated by the Plasma Protein Beta 2-Glycoprotein I. Sci Rep (2016) 0.75
Formal Modeling of mTOR Associated Biological Regulatory Network Reveals Novel Therapeutic Strategy for the Treatment of Cancer. Front Physiol (2017) 0.75
KEGG for linking genomes to life and the environment. Nucleic Acids Res (2007) 49.37
Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med (2001) 46.58
Pathogen recognition and innate immunity. Cell (2006) 44.14
Functional discovery via a compendium of expression profiles. Cell (2000) 31.39
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol (2010) 24.08
The pathophysiology and treatment of sepsis. N Engl J Med (2003) 21.67
Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science (2003) 17.57
Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity (1999) 17.40
Function and activation of NF-kappa B in the immune system. Annu Rev Immunol (1994) 17.04
Systems biology: a brief overview. Science (2002) 14.69
Toll-like receptors in innate immunity. Int Immunol (2005) 12.24
Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol (2009) 11.76
Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity (1999) 11.64
Reactome: a database of reactions, pathways and biological processes. Nucleic Acids Res (2010) 11.23
Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity (2011) 11.15
Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med (2007) 10.02
Modeling and simulation of genetic regulatory systems: a literature review. J Comput Biol (2002) 9.97
Negative regulation of toll-like receptor-mediated immune responses. Nat Rev Immunol (2005) 9.70
The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat Immunol (2004) 9.42
Cell-signalling dynamics in time and space. Nat Rev Mol Cell Biol (2006) 7.25
SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol (2007) 6.89
LPS/TLR4 signal transduction pathway. Cytokine (2008) 6.60
Treating patients with severe sepsis. N Engl J Med (1999) 6.56
Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat Immunol (2005) 6.13
Harmful molecular mechanisms in sepsis. Nat Rev Immunol (2008) 6.03
LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF. J Exp Med (2003) 5.97
Proinflammatory cytokines. Chest (2000) 5.89
Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell (2002) 5.44
JAK-STAT signaling: from interferons to cytokines. J Biol Chem (2007) 5.28
Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis (2013) 5.00
TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat Immunol (2003) 4.94
The JAK-STAT signaling pathway: input and output integration. J Immunol (2007) 4.92
Achieving stability of lipopolysaccharide-induced NF-kappaB activation. Science (2005) 4.83
Anti-inflammatory cytokines. Chest (2000) 4.74
TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages. Nat Immunol (2002) 4.63
Dynamical behaviour of biological regulatory networks--I. Biological role of feedback loops and practical use of the concept of the loop-characteristic state. Bull Math Biol (1995) 4.59
Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007. Crit Care Med (2012) 4.45
The ACCP-SCCM consensus conference on sepsis and organ failure. Chest (1992) 4.35
Network dynamics and cell physiology. Nat Rev Mol Cell Biol (2001) 4.22
Signaling through the JAK/STAT pathway, recent advances and future challenges. Gene (2002) 4.15
The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling. Nat Immunol (2006) 3.41
The interface between innate and adaptive immunity. Nat Immunol (2004) 3.28
Pathophysiology of sepsis. Am J Pathol (2007) 3.19
Sepsis syndromes: understanding the role of innate and acquired immunity. Shock (2001) 3.11
Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis (2000) 3.03
Toward an epidemiology and natural history of SIRS (systemic inflammatory response syndrome) JAMA (1993) 2.88
PANTHER pathway: an ontology-based pathway database coupled with data analysis tools. Methods Mol Biol (2009) 2.76
Regulation of cytokine signaling and inflammation. Cytokine Growth Factor Rev (2002) 2.69
Molecular mechanisms of endotoxin tolerance. J Endotoxin Res (2004) 2.60
The search for effective therapy for sepsis: back to the drawing board? JAMA (2011) 2.46
Sepsis: definition, epidemiology, and diagnosis. BMJ (2007) 2.43
Balance of inflammatory cytokines related to severity and mortality of murine sepsis. Infect Immun (1996) 2.43
Rip1 mediates the Trif-dependent toll-like receptor 3- and 4-induced NF-{kappa}B activation but does not contribute to interferon regulatory factor 3 activation. J Biol Chem (2005) 2.41
Genetic control of flower morphogenesis in Arabidopsis thaliana: a logical analysis. Bioinformatics (1999) 2.39
Different Toll-like receptor agonists induce distinct macrophage responses. J Leukoc Biol (2001) 2.32
The cytokine-inducible zinc finger protein A20 inhibits IL-1-induced NF-kappaB activation at the level of TRAF6. FEBS Lett (1999) 2.12
Differential induction of the toll-like receptor 4-MyD88-dependent and -independent signaling pathways by endotoxins. Infect Immun (2005) 2.05
A critical role for IRAK4 kinase activity in Toll-like receptor-mediated innate immunity. J Exp Med (2007) 2.03
NF-kappaB family of transcription factors: central regulators of innate and adaptive immune functions. Clin Microbiol Rev (2002) 1.97
Toll-like receptors as an escape mechanism from the host defense. Trends Microbiol (2004) 1.97
The compensatory anti-inflammatory response syndrome (CARS) in critically ill patients. Clin Chest Med (2008) 1.86
Suppressor of cytokine signaling (SOCS) proteins indirectly regulate toll-like receptor signaling in innate immune cells. J Biol Chem (2004) 1.86
Anti-endotoxin monoclonal antibodies--a second look. N Engl J Med (1992) 1.73
Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding. Physiol Rev (2013) 1.72
Proinflammatory cytokines and sepsis syndrome: not enough, or too much of a good thing? Trends Immunol (2003) 1.70
Role of interferons and other cytokines in the regulation of the immune response. APMIS (1995) 1.61
A network model for the control of the differentiation process in Th cells. Biosystems (2005) 1.59
Search for sepsis drugs goes on despite past failures. Science (1994) 1.45
Application of formal methods to biological regulatory networks: extending Thomas' asynchronous logical approach with temporal logic. J Theor Biol (2004) 1.43
Cytokine therapeutics for the treatment of sepsis: why has nothing worked? Curr Pharm Des (2003) 1.42
The TRAF-associated protein TANK facilitates cross-talk within the IkappaB kinase family during Toll-like receptor signaling. Proc Natl Acad Sci U S A (2011) 1.41
Laws for the dynamics of regulatory networks. Int J Dev Biol (1998) 1.38
Endotoxin, TLR4 signaling and vascular inflammation: potential therapeutic targets in cardiovascular disease. Curr Pharm Des (2006) 1.34
Multistationarity, the basis of cell differentiation and memory. II. Logical analysis of regulatory networks in terms of feedback circuits. Chaos (2001) 1.28
The role of TRAF6 in signal transduction and the immune response. Microbes Infect (2004) 1.23
Increased expression of toll-like receptor-2 and -4 on leukocytes from patients with sepsis. Shock (2004) 1.22
Role of Toll-like receptor responses for sepsis pathogenesis. Immunobiology (2007) 1.20
Suppressors of cytokine signaling (SOCS): inhibitors of the JAK/STAT pathway. Shock (2002) 1.18
Type I IFN modulates host defense and late hyperinflammation in septic peritonitis. J Immunol (2006) 1.18
Modeling approaches for qualitative and semi-quantitative analysis of cellular signaling networks. Cell Commun Signal (2013) 1.17
Anti-inflammatory response is associated with mortality and severity of infection in sepsis. Am J Physiol Lung Cell Mol Physiol (2004) 1.17
Logical modelling of gene regulatory networks with GINsim. Methods Mol Biol (2012) 1.15
Segmenting the fly embryo: a logical analysis of the pair-rule cross-regulatory module. J Theor Biol (2003) 1.15
Cytokine elaboration in critically ill infants with bacterial sepsis, necrotizing entercolitis, or sepsis syndrome: correlation with clinical parameters of inflammation and mortality. J Pediatr (2005) 1.14
Production of IFN-β during Listeria monocytogenes infection is restricted to monocyte/macrophage lineage. PLoS One (2011) 1.12
Logical analysis of systems comprising feedback loops. J Theor Biol (1978) 1.09
Immune status and inflammatory response differ locally and systemically in severe acute pancreatitis. Scand J Gastroenterol (2006) 1.09
A TIR domain variant of MyD88 adapter-like (Mal)/TIRAP results in loss of MyD88 binding and reduced TLR2/TLR4 signaling. J Biol Chem (2009) 1.09
Are SOCS suppressors, regulators, and degraders? J Leukoc Biol (2003) 1.06
Pro- and anti-inflammatory responses are regulated simultaneously from the first moments of septic shock. Eur Cytokine Netw (2011) 1.05
SOCS1 regulates the IFN but not NFkappaB pathway in TLR-stimulated human monocytes and macrophages. J Immunol (2008) 1.03
Mixed antagonist response and sepsis severity-dependent dysbalance of pro- and anti-inflammatory responses at the onset of postoperative sepsis. Immunobiology (2011) 1.01
Jaks, STATs, Cytokines, and Sepsis. Clin Diagn Lab Immunol (2002) 1.00
Anti-inflammatory cytokine response and the development of multiple organ failure in severe sepsis. Acta Anaesthesiol Scand (2003) 0.96
From molecular networks to qualitative cell behavior. FEBS Lett (2005) 0.95
Should we inhibit type I interferons in sepsis? Infect Immun (2006) 0.92
IFN-beta1a and IFN-beta1b have different patterns of influence on cytokines. Clin Neurol Neurosurg (2004) 0.90
A dual negative regulation model of Toll-like receptor 4 signaling for endotoxin preconditioning in human endotoxemia. Math Biosci (2011) 0.89
Expression of tumour necrosis factor receptor and Toll-like receptor 2 and 4 on peripheral blood leucocytes of human volunteers after endotoxin challenge: a comparison of flow cytometric light scatter and immunofluorescence gating. Clin Exp Immunol (2005) 0.89
Positive feedback circuits and memory. C R Acad Sci III (2000) 0.87